StockpollyBeta
Get App
Popularity #3,002
BDSX · NASDAQ · Medical - Diagnostics & Research

Biodesix (BDSX)

Uses multi-omic testing to address clinical questions in lung disease.

$28.84
vs last close+0.69 (+2.45%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue131515181820182022292627
Cost of revenue333444444545
Gross profit101112141416141618242122
171823222323232625262827
Research & development222332333333
151621202020202222232424
Selling & marketing0−190000000000
General & administrative03500000000024
Other expenses000000000000
Operating income−7−7−11−8−9−7−9−10−7−2−6−5
−4−2−3−3−2−2−2−2−2−2−2−2
Interest expense223222222222
Other non-operating income100100000000
Income before tax−11−9−14−11−10−8−11−11−9−4−8−7
Net income from continuing operations−11−9−14−11−10−8−11−11−9−4−8−7
Net income−11−9−14−11−10−8−11−11−9−4−8−7
EPS, basic−$0.14−$1.98−$2.80−$1.70−$1.40−$1.13−$1.51−$1.56−$1.16−$0.49−$0.81−$0.71
EPS, diluted−$0.14−$1.98−$2.80−$1.70−$1.40−$1.13−$1.51−$1.56−$1.16−$0.49−$0.81−$0.71
Weighted average shares, basic805567777881010
Weighted average shares, diluted805567777881010
EBITDA−7−6−10−8−7−5−8−8−5−1−4−4
Depreciation & amortization111111111111
EBIT−9−7−11−9−8−6−9−10−7−2−6−5